Science 37
Business Combination with LifeSci Acquisition II Corp.

Science 37 enables universal access to clinical research—making it easier for patients and providers to participate and accelerating the development of new and innovative treatments that impact patient lives.

More Like This

Nov 2022
OmniAb Logo

Closing of Business Combination with Avista Public Acquisition Corp. II (NASDAQ: AHPA)

Capital Markets Advisor

View Details >
Aug 2022

Business Combination with Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA)

Financial Advisor

View Details >
Dec 2021

Business Combination with Thimble Point Acquisition Corp.

Capital Markets Advisor

View Details >